In an unexpected twist, Novartis has gotten caught up in the messy investigation into Michael Cohen, President Trump’s personal attorney.
The drug maker confirmed it entered into a previously undisclosed agreement last year with Essential Consultants, which is reportedly a shell company that Cohen used to make payments for various matters.
The drug maker also said Wednesday it had been contacted in November 2017 by lawyers from Special Counsel Robert Mueller’s office regarding the agreement with Essential Consultants. “Novartis cooperated fully with the Special Counsel’s office and provided all the information requested. Novartis considers this matter closed as to itself and is not aware of any outstanding questions regarding the agreement.”
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.
Already have an account? Log in
To submit a correction request, please visit our Contact Us page.